Education
About Us
Working with TipRanks
Follow Us
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
RESEARCH TOOLSreports
Total Valuation
Marvel Biosciences Corp has a market cap or net worth of C$9.53M. The enterprise value is C$10.32M.
Market CapC$9.53M
Enterprise ValueC$10.32M
Share Statistics
Marvel Biosciences Corp has 52,953,730 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding52,953,730
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Marvel Biosciences Corp’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.11%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)0.11%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio-2.72
Price to Fair Value-1.70
Price to FCF-7.76
Price to Operating Cash Flow-6.84
PEG Ratio-0.89
Income Statement
In the last 12 months, Marvel Biosciences Corp had revenue of 0.00 and earned -1.65K in profits. Earnings per share was -41.30.
Revenue0.00
Gross Profit0.00
Operating Income-1.22K
Pretax Income-1.65K
Net Income-1.65K
EBITDA-1.54M
Earnings Per Share (EPS)-41.30
Cash Flow
In the last 12 months, operating cash flow was -1.16M and capital expenditures 4.00, giving a free cash flow of -1.16M billion.
Operating Cash Flow-1.16M
Free Cash Flow-1.16M
Free Cash Flow per Share-0.02
Dividends & Yields
Marvel Biosciences Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.44
52-Week Price Change41.67%
50-Day Moving Average0.11
200-Day Moving Average0.13
Relative Strength Index (RSI)63.62
Average Volume (3m)58.90K
Important Dates
Marvel Biosciences Corp upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Marvel Biosciences Corp as a current ratio of 0.31, with Debt / Equity ratio of -58.45%
Current Ratio0.31
Quick Ratio0.31
Debt to Market Cap0.36
Net Debt to EBITDA-0.89
Interest Coverage Ratio-0.01
Taxes
In the past 12 months, Marvel Biosciences Corp has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Marvel Biosciences Corp EV to EBITDA ratio is -4.01, with an EV/FCF ratio of -5.22.
EV to Sales0.00
EV to EBITDA-4.01
EV to Free Cash Flow-5.22
EV to Operating Cash Flow-5.22
Balance Sheet
Marvel Biosciences Corp has C$389.02K in cash and marketable securities with C$1.71M in debt, giving a net cash position of C$1.32M billion.
Cash & Marketable SecuritiesC$389.02K
Total DebtC$1.71M
Net CashC$1.32M
Net Cash Per ShareC$0.02
Tangible Book Value Per Share-C$0.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Marvel Biosciences Corp is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―